Viewing Study NCT05342857


Ignite Creation Date: 2025-12-24 @ 6:34 PM
Ignite Modification Date: 2026-06-28 @ 1:37 PM
Study NCT ID: NCT05342857
Status: UNKNOWN
Last Update Posted: 2022-04-25
First Post: 2022-04-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Maximum Treatment Interval With Aflibercept T&E
Sponsor: Shin Kong Wu Ho-Su Memorial Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neovascular Age-related Macular Degeneration View
Keywords: